Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Freedman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Infection and Immunity|January 16, 2019
Potential Therapeutic Effects of Mepacrine against <i>Clostridium perfringens</i> Enterotoxin in a Mouse Model of EnterotoxemiaMauricio A Navarro, Archana Shrestha, John C Freedman, et al.
Research in Microbiology|October 7, 2014
Clostridium perfringens type A-E toxin plasmidsJohn C Freedman, James R Theoret, Jessica A Wisniewski, et al.
Infection and Immunity|March 20, 2014
Clostridium perfringens type A enterotoxin damages the rabbit colonJorge P Garcia, Jihong Li, Archana Shrestha, et al.
FEMS Immunology and Medical Microbiology|December 25, 2009
Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferiJohn C Freedman, Elizabeth A Rogers, Jessica L Kostick, et al.
Infection and Immunity|April 25, 2018
Evidence that Clostridium perfringens Enterotoxin-Induced Intestinal Damage and Enterotoxemic Death in Mice Can Occur Independently of Intestinal Caspase-3 ActivationJohn C Freedman, Mauricio A Navarro, Eleonora Morrell, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2018
The <i>Borrelia burgdorferi</i> c-di-GMP Binding Receptors, PlzA and PlzB, Are Functionally DistinctJessica L Kostick-Dunn, Jerilyn R Izac, John C Freedman, et al.
Infection and Immunity|April 30, 2014
Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loopsMenglin Ma, Abhijit Gurjar, James R Theoret, et al.
The Journal of Investigative Dermatology|September 25, 2020
Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital IchthyosisJohn C Freedman, Trevor J Parry, Peipei Zhang, et al.
Future Microbiology|April 26, 2014
Towards an understanding of the role of Clostridium perfringens toxins in human and animal diseaseFrancisco A Uzal, John C Freedman, Archana Shrestha, et al.
Pathogens and Disease|November 18, 2016
Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functionsKatherine L Mallory, Daniel P Miller, Lee D Oliver, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Infection and Immunity|January 16, 2019
Potential Therapeutic Effects of Mepacrine against <i>Clostridium perfringens</i> Enterotoxin in a Mouse Model of EnterotoxemiaMauricio A Navarro, Archana Shrestha, John C Freedman, et al.
Research in Microbiology|October 7, 2014
Clostridium perfringens type A-E toxin plasmidsJohn C Freedman, James R Theoret, Jessica A Wisniewski, et al.
Infection and Immunity|March 20, 2014
Clostridium perfringens type A enterotoxin damages the rabbit colonJorge P Garcia, Jihong Li, Archana Shrestha, et al.
FEMS Immunology and Medical Microbiology|December 25, 2009
Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferiJohn C Freedman, Elizabeth A Rogers, Jessica L Kostick, et al.
Infection and Immunity|April 25, 2018
Evidence that Clostridium perfringens Enterotoxin-Induced Intestinal Damage and Enterotoxemic Death in Mice Can Occur Independently of Intestinal Caspase-3 ActivationJohn C Freedman, Mauricio A Navarro, Eleonora Morrell, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2018
The <i>Borrelia burgdorferi</i> c-di-GMP Binding Receptors, PlzA and PlzB, Are Functionally DistinctJessica L Kostick-Dunn, Jerilyn R Izac, John C Freedman, et al.
Infection and Immunity|April 30, 2014
Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loopsMenglin Ma, Abhijit Gurjar, James R Theoret, et al.
The Journal of Investigative Dermatology|September 25, 2020
Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital IchthyosisJohn C Freedman, Trevor J Parry, Peipei Zhang, et al.
Future Microbiology|April 26, 2014
Towards an understanding of the role of Clostridium perfringens toxins in human and animal diseaseFrancisco A Uzal, John C Freedman, Archana Shrestha, et al.
Pathogens and Disease|November 18, 2016
Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functionsKatherine L Mallory, Daniel P Miller, Lee D Oliver, et al.
Pageof 3